INTERLEUKIN GENETICS INC

Profile

Company Names

INTERLEUKIN GENETICS INC

Addresses

135 BEAVER ST, WATHAM, MA 02452

135 BEAVER STREET, WATHAM, MA 02452

Phone Numbers

1-781-398-0700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$25,617,500.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-07-29 
$5,592,500.00 
$5,592,500.00 
$0.00 
Equity 
3
2014-12-23 
$5,025,000.00 
$5,025,000.00 
$0.00 
Equity 
2
2013-05-17 
$12,000,000.00 
$17,000,000.00 
$5,000,000.00 
Equity 
1
2012-06-29 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEWIS 
H. 
BENDER 
EXECUTIVE OFFICER, DIRECTOR
INTERLEUKIN GENETICS INC   |  INTENSITY THERAPEUTICS, INC.
MARK 
B. 
CARBEAU 
EXECUTIVE OFFICER, DIRECTOR
INTERLEUKIN GENETICS INC
LIONEL 
 
CARNOT 
DIRECTOR
NEXUS DX, INC.   |  INTERLEUKIN GENETICS INC   |  NABSYS INC   |  MADRIGAL PHARMACEUTICALS, INC.
MARY 
 
CHOWNING 
DIRECTOR
INTERLEUKIN GENETICS INC
ROGER 
 
COLMAN 
DIRECTOR
INTERLEUKIN GENETICS INC   |  KINDEX PHARMACEUTICALS, INC.
ROGER 
C. 
COLMAN 
DIRECTOR
INTERLEUKIN GENETICS INC
THOMAS 
 
CURRAN 
DIRECTOR
INTERLEUKIN GENETICS INC   |  ORY CORP.
STEPHEN 
 
DIPALMA 
EXECUTIVE OFFICER
INTERLEUKIN GENETICS INC   |  SOLID BIOSCIENCES INC.
CATHERINE 
 
EHRENBERGER 
DIRECTOR
INTERLEUKIN GENETICS INC
GORAN 
 
JURKOVIC 
DIRECTOR
INTERLEUKIN GENETICS INC
KENNETH 
 
KORNMAN 
EXECUTIVE OFFICER, DIRECTOR
INTERLEUKIN GENETICS INC
KENNETH 
S. 
KORNMAN 
EXECUTIVE OFFICER, DIRECTOR
INTERLEUKIN GENETICS INC
JOSEPH 
 
LANDSTRA 
DIRECTOR
INTERLEUKIN GENETICS INC
JOSEPH 
M. 
LANDSTRA 
DIRECTOR
INTERLEUKIN GENETICS INC
ELIOT 
M. 
LURIER 
EXECUTIVE OFFICER
INTERLEUKIN GENETICS INC
WILLIAM 
 
MILLS 
DIRECTOR
INTERLEUKIN GENETICS INC   |  CHRONIC CARE MANAGEMENT, INC.
WILLIAM 
 
MILLS III 
DIRECTOR
INTERLEUKIN GENETICS INC
WILLIAM 
C. 
MILLS III 
DIRECTOR
INTERLEUKIN GENETICS INC   |  STEREOTAXIS, INC.
WILLIAM 
C. 
MILLS, III 
DIRECTOR
INTERLEUKIN GENETICS INC
DAYTON 
 
MISFELDT 
DIRECTOR
SUNESIS PHARMACEUTICALS INC   |  NEXTWAVE PHARMACEUTICALS INC   |  ACIEX THERAPEUTICS, INC.   |  INTERLEUKIN GENETICS INC   |  TRIA BEAUTY, INC.
SCOTT 
 
SNYDER 
EXECUTIVE OFFICER
INTERLEUKIN GENETICS INC   |  GENETICURE LLC   |  GENETICURE INC.
JAMES 
 
WEAVER 
DIRECTOR
INTERLEUKIN GENETICS INC   |  SMARTYPIG LLC   |  ALL TRAFFIC SOLUTIONS, INC.   |  MILESTONE BRANDS, LLC   |  BAMF INVESTMENT PARTNERS, LLC   |  327 KG, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-08-11
D
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2016-07-29 
2015-01-08
D
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2014-12-23 
2013-05-30
D
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2013-05-17 
2012-07-11
D
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2012-06-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
BTIG, LLC
122225
NONE
NONE
BTIG, LLC
122225